Dr. James M. Pusey has been appointed vice president and general manager of MDS Pharma Services global clinical development business, which manages late-stage drug trials. Dr. Pusey has more than 25 years of experience in medicine, global clinical trial management, CRO services, and global pharmaceutical sales, marketing and operations. Dr. Pusey will lead a business area that is focused on enhancing client service through its LeanSigma and other initiatives to improve process efficiency and support client needs.

Prior to joining the company, he was president and chief executive officer of OrthoLogic, Inc., a biotech company, where he established a strategic plan involving collaborative agreements and acquisitions. Prior to that he was executive vice president for Neurology at Serono, Inc., where he was responsible for late-stage drug development, including development projects with Pfizer. He has also held the positions of vice president of marketing and therapeutic area leader for central nervous system, pain and infection at Astra-Zeneca.

"Dr. Pusey's vast industry experience combined with his medical background will enhance our ability to assess client needs and provide exceptional service managing their most demanding clinical trials," said MDS Pharma Services president David Spaight.